Ameriprise
HHS icon

Ameriprise’s Harte-Hanks HHS Stock Holding History

Ameriprise’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-22,864
Closed -$371K – 3911
2016
Q3 		$371K Buy
22,864
+308
+1% +$5.07K ﹤0.01% 3303
2016
Q2 		$359K Buy
22,556
+908
+4% +$16K ﹤0.01% 3307
2016
Q1 		$548K Buy
21,648
+230
+1% +$7.07K ﹤0.01% 3125
2015
Q4 		$694K Sell
21,418
-786
-4% -$29.4K ﹤0.01% 3106
2015
Q3 		$784K Buy
22,204
+2,099
+10% +$94.7K ﹤0.01% 3081
2015
Q2 		$1.2M Buy
20,105
+377
+2% +$25.4K ﹤0.01% 3042
2015
Q1 		$1.54M Buy
19,728
+810
+4% +$62.6K ﹤0.01% 2717
2014
Q4 		$1.46M Buy
18,918
+41
+0.2% +$2.68K ﹤0.01% 2690
2014
Q3 		$1.2M Buy
18,877
+343
+2% +$23.3K ﹤0.01% 2707
2014
Q2 		$1.33M Buy
18,534
+739
+4% +$57.1K ﹤0.01% 2672
2014
Q1 		$1.57M Buy
17,795
+362
+2% +$28.2K ﹤0.01% 2574
2013
Q4 		$1.36M Buy
17,433
+579
+3% +$47.2K ﹤0.01% 2573
2013
Q3 		$1.49M Buy
16,854
+644
+4% +$58.9K ﹤0.01% 2556
2013
Q2 		$1.39M Buy
+16,210
New +$1.34M ﹤0.01% 2506

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ameriprise's HHS Position: Q4 2016 in Review

Ameriprise sold out of Harte-Hanks (HHS) in Q4 2016, closing a stake of 22,864 shares — an estimated $371K sold.

Ameriprise first reported a position in HHS in Q2 2013 and held it in 14 quarters. The position peaked at $1.57M in Q1 2014. 86 funds tracked by Wall St. Rank hold HHS as of Q4 2016.

  • Ameriprise reported no remaining Harte-Hanks position as of Q4 2016 after selling out during the quarter.
  • Ameriprise sold 22,864 Harte-Hanks shares in Q4 2016, an estimated $371K.
  • Ameriprise first reported a position in Harte-Hanks in Q2 2013 and held it in 14 quarters.
  • Ameriprise's Harte-Hanks position peaked at $1.57M in Q1 2014.
  • 86 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2016.

Based on Ameriprise's 13F filing for Q4 2016, filed 3 Feb 2017.